AMRX Amneal Pharmaceuticals, Inc.

NASDAQ
$19.91

Amneal Pharmaceuticals, Inc. (AMRX) Institutional Ownership

What the institutions did with AMRX last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended September 30, 2026.

Managers compared
3
filed both this quarter and last
Managers holding
3
+0 on the quarter
Buyers
2
0 opened new
Sellers
0
0 sold out entirely
Buyer share
100.0%
of managers who traded it
Breadth
+100.0
net buyers, as a share of those trading

Only 3 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
Stonebridge Financial Group, LLC 36.1K 91.7%
Versant Capital Management, Inc 2.6K 6.7%
MassMutual Private Wealth & Trust, FSB 652 1.7%

Largest changes

Manager Action Previous Current Change
Versant Capital Management, Inc Increased 2.6K 2.6K +66
Stonebridge Financial Group, LLC Increased 36.1K 36.1K +2

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.